Provided by Tiger Fintech (Singapore) Pte. Ltd.

ReShape Lifesciences, Inc.

2.38
-0.0600-2.46%
Post-market: 2.390.0100+0.42%19:58 EDT
Volume:125.99K
Turnover:304.45K
Market Cap:5.68M
PE:-0.01
High:2.50
Open:2.45
Low:2.36
Close:2.44
Loading ...
Jun 22, 2021

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Jun 22, 2021

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Jun 22, 2021

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Jun 22, 2021

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Jun 22, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 21, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 15, 2021

Major Issues Report

8-K - Current report
Jun 15, 2021

Major Issues Report

8-K - Current report
Jun 15, 2021

Major Issues Report

8-K - Current report
May 26, 2021

Major Issues Report

8-K - Current report
May 21, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 21, 2021

Major Issues Report

8-K - Current report
May 19, 2021

Major Issues Report

8-K - Current report
May 18, 2021

Major Issues Report

8-K - Current report
May 18, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 18, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 17, 2021

Major Issues Report

8-K - Current report
May 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
May 13, 2021

Major Issues Report

8-K - Current report